Combination therapy of α -blockers and antidepressive drug for treatment of CP/CPPS

Kong Liang,Bai Qiang,Huang Yichen,Chen Jianhua,Qi Jun,Chen Fang
DOI: https://doi.org/10.3969/j.issn.1008-0848.2008.06.015
2008-01-01
Abstract:Objective To investigate the effect of treatment with a-receptor inhibitor and antidepressive drug in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Methods A total of 48 patients with CP/CPPS were enrolled in this study. Whose age range is from 20 to 50 years old, (Mean age 30). All patients had symptoms of pain in the region of perineum, urine frequency, mental stress and anxiety. All of them had been treated with antibiotics but with poor effect. Mean course of disease was 10 (range from 3 to 24) months. All patients received 3-months-combination therapy of α-receptor inhibitor (doxazosin 4mg/d or tamsulosin 2mg/d) and antidepressive drug (sertraline 50mg/d or venlafaxine75~150mg/d). And then they were evaluated at time pretreatment and 4, 8, 12 weeks posttreatment respectvely by the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) and adverse events. Assessment criteria: (1)marked effective: decrease of NIH-CPSI score was more than 15; (2)effective: the decrease of NIH-CPSI score was more than 5; (3)no effective: decrease of NIH-CPSI score was less than 5. The total effective rate was the sum of marked effective rate and effective rate. Results There were 16 patients with marked effective, 25 patients with effective and 4 cases with no effect. Total effective rate was 91 percent (41/45). Two patients withdrew the treatment due to adverse drug reaction in this study. Conclusion Combination therapy of α-receptor inhibitor and antidepressive drug is safe and effective in managing CP/CPPS patients.
What problem does this paper attempt to address?